Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Use of lacosamide in children with refractory epilepsy.

Buck ML, Goodkin HP.

J Pediatr Pharmacol Ther. 2012 Jul;17(3):211-9. doi: 10.5863/1551-6776-17.3.211.

PMID:
23258963
[PubMed]
Free PMC Article
2.

Lacosamide: an adjunctive agent for partial-onset seizures and potential therapy for neuropathic pain.

Harris JA, Murphy JA.

Ann Pharmacother. 2009 Nov;43(11):1809-17. doi: 10.1345/aph.1M303. Epub 2009 Oct 20. Review.

PMID:
19843834
[PubMed - indexed for MEDLINE]
3.

Pharmacotherapy of epilepsy: newly approved and developmental agents.

Stephen LJ, Brodie MJ.

CNS Drugs. 2011 Feb;25(2):89-107. doi: 10.2165/11584860-000000000-00000. Review.

PMID:
21254787
[PubMed - indexed for MEDLINE]
4.

Lacosamide in refractory mixed pediatric epilepsy: a prospective add-on study.

Rastogi RG, Ng YT.

J Child Neurol. 2012 Apr;27(4):492-5. doi: 10.1177/0883073812436741.

PMID:
22467791
[PubMed - indexed for MEDLINE]
5.

Efficacy of lacosamide as adjunctive therapy in children with refractory epilepsy.

Yorns WR Jr, Khurana DS, Carvalho KS, Hardison HH, Legido A, Valencia I.

J Child Neurol. 2014 Jan;29(1):23-7. doi: 10.1177/0883073812462887. Epub 2012 Nov 8.

PMID:
23143718
[PubMed - indexed for MEDLINE]
6.

Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.

Casas-Fernández C, Martínez-Bermejo A, Rufo-Campos M, Smeyers-Durá P, Herranz-Fernández JL, Ibáñez-Micó S, Campistol-Plana J, Alarcón-Martínez H, Campos-Castelló J.

Drugs R D. 2012 Dec 1;12(4):187-97. doi: 10.2165/11636260-000000000-00000.

PMID:
23193979
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.

Chung S, Ben-Menachem E, Sperling MR, Rosenfeld W, Fountain NB, Benbadis S, Hebert D, Isojärvi J, Doty P.

CNS Drugs. 2010 Dec;24(12):1041-54. doi: 10.2165/11586830-000000000-00000.

PMID:
21090838
[PubMed - indexed for MEDLINE]
8.

Rufinamide: a new antiepileptic medication for the treatment of seizures associated with lennox-gastaut syndrome.

Wisniewski CS.

Ann Pharmacother. 2010 Apr;44(4):658-67. doi: 10.1345/aph.1M679. Epub 2010 Mar 16. Review.

PMID:
20233912
[PubMed - indexed for MEDLINE]
9.

Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.

Husain A, Chung S, Faught E, Isojarvi J, McShea C, Doty P.

Epilepsia. 2012 Mar;53(3):521-8. doi: 10.1111/j.1528-1167.2012.03407.x.

PMID:
22372628
[PubMed - indexed for MEDLINE]
10.

Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis.

Sawh SC, Newman JJ, Deshpande S, Jones PM.

PeerJ. 2013 Aug 6;1:e114. doi: 10.7717/peerj.114. Print 2013.

PMID:
23940830
[PubMed]
Free PMC Article
11.

Lacosamide: an investigational drug for adjunctive treatment of partial-onset seizures.

Ben-Menachem E.

Drugs Today (Barc). 2008 Jan;44(1):35-40. doi: 10.1358/dot.2008.44.1.1178468. Review.

PMID:
18301802
[PubMed - indexed for MEDLINE]
12.

Retigabine (ezogabine) as add-on therapy for partial-onset seizures: an update for clinicians.

Harris JA, Murphy JA.

Ther Adv Chronic Dis. 2011 Nov;2(6):371-6. doi: 10.1177/2040622311421542.

PMID:
23251762
[PubMed]
Free PMC Article
13.

Lacosamide as an adjunctive therapy in pediatric patients with refractory focal epilepsy.

Kim JS, Kim H, Lim BC, Chae JH, Choi J, Kim KJ, Hwang YS, Hwang H.

Brain Dev. 2014 Jun;36(6):510-5. doi: 10.1016/j.braindev.2013.07.003. Epub 2013 Aug 12.

PMID:
23948372
[PubMed - in process]
14.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

PMID:
15842952
[PubMed - indexed for MEDLINE]
Free Article
15.

Profile of lacosamide and its role in the long-term treatment of epilepsy: a perspective from the updated NICE guideline.

Nunes VD, Sawyer L, Neilson J, Sarri G, Cross JH.

Neuropsychiatr Dis Treat. 2013;9:467-76. doi: 10.2147/NDT.S32081. Epub 2013 Apr 8.

PMID:
23630422
[PubMed]
Free PMC Article
16.

Novel medications for epilepsy.

Fattore C, Perucca E.

Drugs. 2011 Nov 12;71(16):2151-78. doi: 10.2165/11594640-000000000-00000. Review.

PMID:
22035515
[PubMed - indexed for MEDLINE]
17.

Preliminary efficacy and safety of lacosamide in children with refractory epilepsy.

Heyman E, Lahat E, Levin N, Berkovitch M, Gandelman-Marton R.

Eur J Paediatr Neurol. 2012 Jan;16(1):15-9. doi: 10.1016/j.ejpn.2011.08.007. Epub 2011 Sep 15.

PMID:
21924653
[PubMed - indexed for MEDLINE]
18.

Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.

Palmer KJ, McTavish D.

Drugs. 1993 Jun;45(6):1041-65. Review.

PMID:
7691493
[PubMed - indexed for MEDLINE]
19.

A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.

Sake JK, Hebert D, Isojärvi J, Doty P, De Backer M, Davies K, Eggert-Formella A, Zackheim J.

CNS Drugs. 2010 Dec;24(12):1055-68. doi: 10.2165/11587550-000000000-00000.

PMID:
21090839
[PubMed - indexed for MEDLINE]
20.

Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy.

Pasha I, Kamate M, Didagi SK.

Pediatr Neurol. 2014 Oct;51(4):509-14. doi: 10.1016/j.pediatrneurol.2014.07.004. Epub 2014 Jul 16.

PMID:
25266613
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk